This study is researching an experimental drug called garetosmab. The study is focused on
adult patients with fibrodysplasia ossificans progressiva (FOP). The aim of the study is to
see how safe and effective the study drug is in patients with FOP.
The study is looking at several other research questions, including:
What side effects may happen from receiving the study drug
How much study drug is in your blood at different times
Whether the body makes antibodies against the study drug (which could make the drug less
effective or could lead to side effects)
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.